Navigation Links
Jubilant DraxImage And Positron Enter Into A Strategic Collaboration On The Sourcing And Supply Of Strontium-82 And Rubidium-82 Generators
Date:9/6/2012

BALTIMORE, Sept. 6, 2012 /PRNewswire/ -- Positron Corporation (OTCBB: POSC), - is pleased to announce that Jubilant DraxImage Inc. (hereinafter "JDI"), a Jubilant Life Sciences Company, and Positron Corporation (hereinafter "Positron"), have executed a Letter of Intent pertaining to:

(a)         Positron's supply of Active Pharmaceutical Ingredient (API) grade Sr-82 for the JDI Sr-82/Rb-82 generator;

(b)      JDI's and Positron's co-promotion of JDI Sr-82/Rb-82 generators to end-users (upon FDA clearance); and

(c)      Positron's lifecycle management for expired JDI Sr-82/Rb-82 generators.

The strategic alliance between JDI and Positron will facilitate the stabilization, security and growth of the industry by increasing the supply of radioisotopes and radiopharmaceuticals. The Parties expect that it will also provide considerable benefits to both Parties: Positron secures a generator supply for future sales of cardiac PET scanners and a customer for Sr-82; JDI secures a reliable supply of Sr-82, a vendor for expired generators management, and a strategic partner with a growing customer base of cardiac PET scanners installed and serviced.

Martyn Coombs, President of Jubilant DraxImage stated, "Through its wholly owned subsidiary, Manhattan Isotope Technology (MIT), Positron positioned itself as the only private entity in the U.S. with the practical experience of servicing the Sr82/Rb82 generator lifecycle.  Their ability to provide a more stable and secure supply of API Sr-82 and management of expired Sr-82/Rb-82 generators fits well with JDI's pre-launch strategy. "

Patrick Rooney, Chief Executive Officer of Positron stated, "JDI has developed a robust Sr82/Rb82 generator and elution system. As the Sr82/Rb82 generator on the market has enjoyed tremendous growth and the merits of the technology have been validated many times over, we strongly believe that the arrival of an alternative, upon the FDA clearance of JDI's generator, will be welcomed by the cardiac PET community."

JDI and Positron expect to complete a Definitive Agreement within 3 months.

About Jubilant DraxImage Inc.:
Jubilant DraxImage Inc., a subsidiary of Jubilant Life Sciences, develops, manufactures and markets diagnostic and therapeutic radiopharmaceuticals for the global nuclear medicine marketplace. Jubilant DraxImage Inc.'s mission is to be a leading global provider of radiopharmaceuticals and value-added enabling technologies. Products include a proprietary line of lyophilized Technetium-99m kits (MAA, MDP, DTPA and Sestamibi). Jubilant DraxImage Inc. is also a leading supplier of I-131 radiopharmaceuticals in North America, used for the diagnosis and treatment of thyroid disorder and cancer. Jubilant DraxImage Inc. products are exported worldwide, with regulatory approvals in USA, South America, parts of Europe and South Asia. More information about Jubilant DraxImage is available at www.draximage.com.

About Positron Corporation:
Positron Corporation (OTCBB:POSC) is a leading molecular imaging healthcare company vertically integrating all the segments of nuclear cardiology—providing an end-to-end solution for cardiac PET.  Through proprietary PET imaging systems, radiopharmaceuticals and radioisotopes solutions, Positron enables healthcare providers to more accurately diagnose disease and improve patient outcomes, while practicing cost effective medicine. Positron's unique products, market position and approach in securing the supply chain are substantial advantages, further accelerating the adoption of cardiac PET and growth of nuclear cardiology.  Positron is redefining the industry. More information about Positron is available at www.positron.com.


'/>"/>
SOURCE Positron Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Positron Accepts Economic Incentives Offer From The City Of Gary, Indiana For $30 Million Towards 70 MeV Cyclotron Project
2. DermTechs Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study
3. Pittsburgh Based ParentPlus Enters Collaboration with Vitrolife
4. Two Top Biological Imaging Centers Offer Powerful Free Online Tool to Researchers, Educators, and Public
5. OvaGene Oncology Collaborates With Moffitt Cancer Center to Develop and Commercialize microRNAs Associated With Chemotherapeutic Drug Response
6. Elsevier Collaborates with the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)
7. CAS and InfoChem Enter Into Long Term Collaboration in ChemInformatics
8. Eye Surgery Center of Michigan First in Southeast Michigan to Perform Bladeless Cataract Surgery Using New LenSx® Laser Technology
9. China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
10. BioStorage Technologies Partners with Susan G. Komen for the Cure Tissue Bank at IU Simon Cancer Center to Raise Money and Awareness for Breast Cancer Research
11. Pacific Meso Center Receives Generous Donation to First Free-Standing Mesothelioma Research Laboratory in Los Angeles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... ... July 25, 2017 , ... ... to announce that its regenerative stem cell therapy has been used on more ... successful treatment for horses with potentially fatal injuries to tendons and ligaments. , ...
(Date:7/26/2017)... FL (PRWEB) , ... July 26, 2017 , ... ... learning algorithms targeted towards leveraging the years of diagnostic excellence by Mayo Clinic ... The first product suite will be distributed through the Microsoft Azure platform ...
(Date:7/25/2017)... (PRWEB) , ... July 25, 2017 , ... Fiberstar, ... food and beverage industry, offers Citri-Fi® 125. This natural citrus fiber is used to ... and extend real tomato in sauces, condiments and spreads. Today, more than ever, consumers ...
(Date:7/24/2017)... 2017 Intralytix, Inc. announced that it received ... French family group. This investment marks the beginning of ... commercialize bacteriophage-based products, for various benefits in human health ... As a global key ... markets innovative solutions for baking, food taste & pleasure, ...
Breaking Biology Technology:
(Date:3/24/2017)... DUBLIN , Mar 24, 2017 Research ... Vehicle Access System Market Analysis & Trends - Industry Forecast to ... ... poised to grow at a CAGR of around 15.1% over the ... This industry report analyzes the market estimates and forecasts for ...
(Date:3/22/2017)... 21, 2017   Neurotechnology , a provider ... today announced the release of the SentiVeillance ... improved facial recognition using up to 10 surveillance, ... computer. The new version uses deep neural-network-based facial ... it utilizes a Graphing Processing Unit (GPU) for ...
(Date:3/20/2017)... March 20, 2017 At this year,s CeBIT Chancellor ... biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand together with ... this year,s CeBIT partner country. At the largest German biometrics company the ... fingerprint, face and iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
Breaking Biology News(10 mins):